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Although vitamin deficiencies are a well-known issue, monitoring of the vitamin status and diagnosis of 
vitamin deficiencies in remote regions is a complicated task. Dried blood microsampling, as an alternative 
sampling strategy, could offer a solution to the several drawbacks related to conventional venipuncture. 
Although highly relevant, the number of microsampling procedures that has been developed for assessing 
vitamins in dried blood samples is rather limited, indicating the challenging nature of the subject. This 
review discusses several challenges inherent to vitamin analysis in microsamples, thereby covering topics 
including sampling strategy, hematocrit (Hct) effect, sample preparation, calibration, assay sensitivity, 
stability, and clinical interpretation of the results. 
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Vitamins are essential micronutrients for humans, as they play a crucial role in the production of 
hormones, enzymes and substances required for the development and growth of the human body (1). 
Vitamins are classified into two major groups: water soluble vitamins (the eight B vitamins and vitamin C) 
and fat soluble vitamins (vitamins A, D, E and K). As the endogenous synthesis of vitamins is absent 
and/or limited in the body, the body requires daily supplementation of these micronutrients through 
intake of vitamin-rich foods, except for vitamin D, which is synthesized from its precursor when the skin 
is exposed to sunlight (1, 2). Although only ‘micro’ amounts of vitamins are required for optimal growth 
and development, inadequate intake and, regarding vitamin D, insufficient exposure to sunlight, may 
lead to vitamin deficiencies.  
Although vitamin deficiencies are a major health problem, affecting more than 25% of the global 
population, monitoring of the vitamin status in remote regions is a complicated task. Since the early 
symptoms of vitamin deficiencies are often nonspecific, early diagnosis relies on the determination of 
the vitamin(s) or other markers in blood, serum or plasma (3). Blood is commonly collected using 
conventional sampling procedures, which is time-consuming and invasive and therefore less suited in 
remote regions due to the absence of medically trained personnel and hygienic measures. Moreover, 
transport typically requires cooling and dedicated logistics. Most of these issues can be overcome by the 
analysis of dried blood microsamples (4-6). 
Dried blood microsampling is a minimally invasive sampling procedure, where small volumes of blood (< 
50 µL) are collected by a simple finger or heel prick and collected on a dedicated absorbent material – 
often filter paper, with the formation of dried blood spots (DBS). Due to the simplified collection 
technique, microsampling does not require dedicated clinical staff and represents limited biohazard, 
which is relevant in remote regions where HIV and malaria may be highly prevalent. In addition, in dried 
samples the stability of compounds is often improved (7). Consequently, microsamples can generally be 
transported and stored under ambient conditions. DBS are also amenable to fully automated analysis, 
allowing an increased sample throughput (8-10). Therefore, DBS sampling may facilitate large-scale 
epidemiological studies in remote areas (11, 12).   
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2. DETERMINATION OF VITAMINS IN DRIED BLOOD MICROSAMPLES 
 Despite the many advantages associated with the analysis of vitamins in dried blood microsamples, the 
number of microsample-based methods for the determination of vitamins is rather limited (Table 1), 
indicating the challenging nature of the subject. Therefore, based on literature and the authors’ own 
experience, this review discusses an overview of the challenges that may be encountered during the set-
up of methods for the determination of vitamins in microsamples, as well as (potential) strategies to 
cope with these challenges. This review solely focuses on the direct determination of the vitamins in 
dried blood microsamples. While the analysis of other biomarkers (which may e.g. indicate a vitamin 
deficiency) is beyond the scope of this review, several points of attention will also be applicable to those. 
2.1. INFLUENCE OF SAMPLING STRATEGY 
Parameters related to the initial sampling should be evaluated in an early stage of method development 
to avoid potential pitfalls in a later stage. For a detailed and thorough overview of the recommended 
aspects that should be evaluated during the set-up and validation of a DBS (or other dried blood 
microsample)-based method, we refer to the official international guideline by Capiau et al. (13). 
Punch size and punch site 
DBS analysis can either be done using whole blood spots or partial DBS punches. For whole blood spot 
analysis, a fixed volume of blood is volumetrically applied onto filter paper, whereafter the whole spot is 
punched out for analysis. Consequently, the hematocrit-(Hct) area-based bias, which is a heavily debated 
issue in quantitative DBS analysis and will be discussed in the next section ‘2.2 Hct-effect’, is avoided. 
However, the deposition of a fixed sample volume onto DBS cards requires the accurate use of 
microcapillaries and pipets, which complicates the sampling procedure and limits the possibility for 
home-sampling (14, 15). Several solutions have become available or are still in development, such as 
HemaPen®, Capitainer® and dried plasma spot (DPS) systems (15-24). Currently, the most used approach 
involves the generation of subpunches from non-volumetrically applied DBS, as this allows a practical 
sampling procedure. However, the analysis of subpunches implies that parameters such as DBS volume 
and (in)homogeneity, in addition to the hematocrit (Hct), need to be taken into account. Recently, Majda 
et al. developed a strategy to calculate the blood volume in a subpunch based on the surfaces of the 
whole blood spot and subpunches (25). However, as the surface depends on the spotted amount of 
blood, such approach is only feasible when using volumetric applications, which is again less ideal in a 
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home-sampling setting.  Finally, the punch size (e.g. 3 mm) may be determined by the analytical 
sensitivity that can or needs to be achieved. 
O’Broin et al. compared folate (vitamin B9) levels in entire DBS samples and 6.35 mm DBS subpunches, 
punched both centrally and peripherally (26). As no significant differences in folate levels were observed, 
the authors concluded that folates were homogeneously distributed in the samples. Nevertheless, it is 
important to fix the position of the punch during the entire method validation and application to ensure 
reproducibility. Preferably, sampling of central punches is recommended as they can be sampled more 
reproducibly (13), which was also observed by Kvaskoff et al. when measuring vitamin D  in subpunches 
(27). A few years later, O’Broin et al.  investigated the distribution of serum folate (SF) in dried serum 
spots (DSS) (28). In contrast to their DBS method, they observed significantly higher SF concentrations in 
DSS punches taken at the edge compared to central DSS punches. Therefore, analysis of complete, 
volumetrically applied DSS, was preferred, to avoid variability due to the punch site.  
For both vitamin A and D, a heterogeneous distribution in DBS samples was demonstrated by Erhardt et 
al. and Kvaskoff et al., respectively (27, 29). Higher concentrations were measured at the periphery 
compared to the center. Similarly, a higher density of sodium, which is highly present in plasma/serum, 
was observed by Erhardt et al. at the periphery of a DBS sample, while the concentration of erythrocytes 
was higher at the center of the spot (29). This latter phenomenon (chromatographic effect) is the result 
of the easier migration of serum/plasma through the filter paper compared to the erythrocytes. 
Therefore, the inhomogeneity of both vitamin A and D in a DBS sample could be explained by the high 
presence of the vitamins in plasma/serum. A few years later, Kvaskoff et al. re-evaluated the distribution 
of vitamin D in DBS samples. Remarkably, this time, concentrations did not depend on the punch site 
(30). The authors hypothesized that differences in hydration or temperature may have influenced the 
analyte distribution. Therefore, the conditions applied at the time of drying must be similar during 
method development, validation and application.  
Type of filter paper and spotting volume 
Besides the punch site and punch size, the type of filter paper may influence the results obtained from 
DBS samples as well. Therefore, different types of filter paper should not be used interchangeably, unless 
equivalence has been demonstrated. The latter was nicely exemplified by Kvaskoff et al., who 
investigated two different types of filter paper (Whatman 903® and FTA®) and found that for depositing 
the same volume of blood, the spot area on FTA® paper was significantly smaller compared to Whatman 
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903® paper (27). In addition, peripheral punches from FTA® were also heavier. The authors concluded 
that on FTA® paper a larger volume of blood was absorbed per surface area. Consequently, 25-hydroxy 
vitamin D3 (25OHD3) levels on FTA® paper, quantified based on calibrators prepared on Whatman 903® 
paper, were overestimated, emphasizing the importance to use the same type of filter paper for the 
preparation of both calibrators and study samples. In addition, as spotting volumes below 50 µL led to 
significantly lower 25OHD3 levels (27), possibly owing to incomplete saturation of the filter paper, the 
authors recommended to spot blood volumes of minimally 50 µL. Typically, blood volumes, ranging from 
20 µL to 70 µL, can be collected, therefore  50 µL, although already substantial for a drop of blood, can 
still be considered as a ‘patient friendly’ sample volume (13). Visual control over the collected blood 
volume can be achieved by using two concentric circles, with the requirement that the inner circle 
should be filled, while the outer circle should not be exceeded (31).  
2.2. HCT EFFECT 
The Hct (i.e. the volume proportion of red blood cells in a blood sample) determines the viscosity of 
blood, and, hence, the spreadability of the blood on filter paper. This results in varying spot sizes when a 
same volume of blood with different Hcts is applied onto filter paper. This Hct-based area bias needs to 
be taken into account when performing partial-punch DBS analysis (14, 15). As the volume of blood in a 
subpunch will vary depending on the Hct, analyte levels in subpunches from DBS samples with a higher 
or lower Hct (compared to the Hct of the blood to generate the calibration line) may be over- or 
underestimated, respectively. For analytes that are primarily (or exclusively) residing in serum, the 
inverse may be observed, as less serum will be contained in a high-Hct DBS subpunch, which may prevail 
the effect of decreased spreading. In line with this, Jensen et al. found that the concentrations of the 
highly plasma protein bound vitamin D were under- and overestimated in DBS subpunches from blood 
with a higher Hct (0.60) respectively lower Hct (0.30) (32). It should be noted, though, that it cannot be 
excluded that a Hct-dependent extractability bias may be responsible for the observed difference, in 
which an analyte is more easily extracted from a DBS prepared from blood with a low Hct (and vice 
versa).  To correct for the variable plasma volume, depending on the Hct, Erhardt et al. determined the 
sodium content to calculate the plasma volume in a DBS sample, assuming a constant sodium 
concentration of 140 nmol/L in plasma (29). Another method using a blood electrolyte was developed by 
Capiau et al., who demonstrated that the Hct of a dried blood sample can be predicted based on the K+ 
content (31, 33, 34). However, as these strategies have to sacrifice part of the sample, Kadjo et al. and 
more recently, Dvorak et al. measured the electrical conductivity of a DBS extract as an equivalent 
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nondestructive method to determine the exact volume of a DBS sample (35, 36). Nevertheless, as 
mentioned by Velghe et al. (15), this technique is based on the strict regulation of electrolyte levels in 
the blood and can therefore not be used in patients with deviating electrolyte levels. Other 
nondestructive, and even noncontact Hct prediction methods have been recently developed, using 
diffuse reflectance or near infrared spectroscopy. These allow preservation of the entire DBS and do not 
require any sample preparation (37-39).  
Alternatively, entire blood spot analysis may be used to eliminate the Hct-based area bias. In addition, 
alternative microsampling techniques have been developed (15), such as volumetric absorptive 
microsampling (VAMS). VAMS devices contain a polymeric tip that absorbs a fixed volume of whole 
blood, independent of the Hct (40, 41). In 2017, Kopp and Rychlik described the determination of 5-
methyltetrahydrofolic acid (5-MTHF) in VAMS samples (42). Even though analysis of whole DBS and 
VAMS samples eliminates the Hct-based area bias, the extraction efficiency of analytes from dried 
samples may still be impacted by the Hct. As mentioned before, analytes may be less efficiently 
extracted from blood with a higher Hct, due to the higher relative amount of erythrocytes, which may 
form an extraction barrier in dried microsamples (14, 15, 41). Since the internal standard (IS) is typically 
only added during the extraction step, it is unable to correct for variations in recovery. Remarkably, from 
the methods listed in Table 1, only two research groups described the evaluation of the influence of Hct 
on the recovery. Both Jensen et al. and Mathew et al. found Hct-independent recoveries for 25-hydroxy 
vitamin D (25OHD) and thiamine diphosphate (TDP), respectively (32, 43). If a Hct-dependent recovery 
would occur, several approaches to avoid the Hct-related recovery bias have been described, such as the 
inclusion of a sonication step or the co-extraction of the IS from dried microsamples (44, 45). 
Furthermore, blood with different Hcts can be considered as a different matrix, as the relative amount of 
plasma to erythrocytes differs. Therefore, varying Hcts may potentially affect the matrix effects (ME) in 
methods using LC-(MS/)MS, and, consequently, may influence the accuracy of the analytical results if no 
suitable stably labelled IS is included to compensate for possible matrix effects (14). For vitamin D 
determination in DBS, all published LC-MS/MS procedures made use of a deuterated analogue (ranging 
from d3-d6)  of vitamin D as IS (Table 1). 
In addition, there is also a physiological aspect to the Hct which relates to the blood/plasma (B/P) ratio of 
an analyte (14). This is of high importance since microsample-based data are usually converted to 
equivalent plasma levels, as reference intervals are commonly established in plasma or serum. The 
degree to which the Hct influences the B/P ratio depends on whether an analyte is predominantly 
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residing in the plasma, potentially bound to plasma proteins, or is mainly present in the erythrocytes. 
Since vitamin A and D are completely excluded from red blood cells and are mainly bound to plasma 
proteins, these vitamins have a low B/P ratio and, for a given plasma concentration, this ratio will 
decrease with increasing Hct. Contrarily, for vitamins mainly present in the erythrocytes, such as 
polyglutamylated folates and the active metabolite of thiamine, thiamine diphosphate (TDP), the B/P 
ratio will increase with increasing Hct. Consequently, the Hct may influence the correlation between DBS 
and plasma concentrations. This latter topic is more elaborately discussed in section 2.7. ‘Clinical 
interpretation’. 
For a more detailed in-depth overview of the Hct issue in dried blood microsamples, and how to cope 
with it, we refer to De Kesel et al. and Velghe et al. (14, 15). 
2.3. SAMPLE PREPARATION 
In addition to the sampling aspect, the use of dried microsamples can also be seen as a strategy to 
facilitate sample preparation, as analytes can be selectively extracted from the card or device, 
consuming lower amounts of reagents (14). Sample cleanup can be established by selective extraction, 
or simple protein precipitation (PP), possibly combined with more elaborate procedures such as liquid-
liquid extraction (LLE) or solid phase extraction (SPE).  
Most methods presented in Table 1 applied a simple PP, using organic solvents such as methanol 
(MeOH) or acetonitrile (ACN), followed by LLE with hexane, to extract the lipophilic vitamin D from a DBS 
sample. However, PP and LLE have been reported to be insufficient to remove phospholipids (PLs), which 
are typically co-extracted from blood when using nonpolar extraction solvents (30). Kvaskoff et al. 
performed, in addition to PP with ACN, a solid phase ion-exchange sample cleanup using ZrO2/TiO2 
medium (30). This medium selectively binds the phosphate groups of phosphatidylcholines, which are 
the major compounds of PLs. This additional purification step led to an overall reduced PL content and 
enhanced vitamin D signal. Although this involved an additional step during sample preparation, multiple 
samples could be processed in parallel using a 96-well format.  Zakaria et al. described the use of 
supported liquid extraction (SLE) to reduce PL interference (46). Although the authors observed an 
increased sensitivity, it was not formally demonstrated that this was really caused by the removal of PLs, 
as hexane, in which PLs are co-extracted, was still used as the elution solvent. It might be that the 
increased sensitivity was caused by the increased extraction of vitamin D using SLE, rather than by the 
removal of PLs.  
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In contrast to vitamin D, none of the methods measuring vitamin A described interferences by PLs, even 
though vitamin A is also a lipophilic vitamin. However, retinol, bound to its binding protein (RBP), was 
initially eluted from the paper using polar solvents, followed by denaturation of the proteins and 
liberation of retinol by an organic solvent. Therefore, the PLs, due to their lipophilic character, were 
likely not co-extracted with the RBP complex and hence, did not interfere with the analysis of retinol. As 
retinol is sensitive to oxidation, extraction solvents contained antioxidants such as ascorbic acid (AA), 
diethylenetriamine pentaacetic acid (DTPA), butylated hydroxytoluene (BHT) or hydroquinone (29, 47-
50).  
Unlike vitamin A and D, hydrophilic vitamins cannot be extracted using pure organic solvents. Therefore, 
trichloroacetic acid or a mixture of MeOH/H2O were described to precipitate the proteins within the 
sample, while still ensuring extraction of the hydrophilic vitamins (B1, B2, B6) (43, 51, 52). Folates (B9) 
were extracted using an aqueous solution containing AA as antioxidant, as folates are sensitive to 
oxidation. Consequently, the advantage of DBS or VAMS as a tool to facilitate sample preparation was 
lost and additional sample purification was needed, such as SPE or filtration. Moreover, by using 
aqueous extraction solvents, samples cannot be concentrated via evaporation and reconstitution, which 
further challenges assay sensitivity.  
In contrast to manual sample preparation, automated extraction, which can be both off- and on-line, 
allows high sample throughput and reduces the risk of human errors (8-11, 53). Recently, Lin et al. 
developed an automated on-line extraction method for the determination of riboflavin (vitamin B2) in 
DBS (52). Riboflavin was extracted from DBS by pumping the extraction solvent (MeOH/H2O (7/3)) 
through the filter paper, whereafter the eluent was directly injected into the LC-MS/MS system. The 
extraction platform was cleaned, followed by extraction of the next sample, which overlapped with the 
LC-MS/MS analysis of the preceding sample. Therefore, sample processing and analysis could be reduced 
to the time required for LC-MS/MS analysis, enhancing throughput. 
2.4. ENDOGENOUS ANALYTES 
The endogenous presence of vitamins in whole blood poses a major challenge during the entire method 
set-up. Important validation parameters, such as selectivity, determination of the Lower Limit of 
Quantitation (LLOQ), recovery, ME and the set-up of a calibration curve, typically use a blank matrix (54, 
55), which is hard to achieve with native samples.  
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Calibrators are ideally prepared in the same matrix as the study samples to avoid differences in 
extraction efficiency and ME. However, it is very difficult, if not impossible, to obtain vitamin-free blood. 
Different approaches to overcome the issue of endogenous analytes have been described, e.g. standard 
addition and the use of an adapted (e.g. washed or charcoal-treated) or surrogate analyte/matrix (56-
58). Both standard addition and the use of a surrogate matrix have been widely used to quantify 
vitamins in microsamples. Alternatively, Fallah et al. constructed a calibration curve based on the 
endogenous retinol plasma concentration: DBS calibrators were prepared by replacing plasma with 
artificial plasma to obtain lower retinol concentrations (48). However, consequently, the highest 
calibrator is limited to the endogenous analyte level.  
Standard addition is one of the most commonly used approaches to quantify vitamins in microsamples. 
Briefly, standard addition is performed by spiking increasing concentrations of the vitamin of interest to 
aliquots of the biological matrix, from which DBS or VAMS samples are prepared and a standard curve 
can be constructed. This approach is not compatible with the direct application of a drop of blood from 
the fingertip onto filter paper. As an alternative, Huang et al. spiked increasing concentrations of retinol 
standard solution to already prepared and dried DBSs, after which the spiked spots were dried (49). 
However, this approach requires caution as there should be no difference in extraction efficiency 
between calibrators and native samples, which is of relevance for the highly protein-bound retinol. A 
major benefit of standard addition is that a calibration curve is set up in the same matrix as the study 
samples, avoiding differences in ME. However, as the endogenous vitamin content is incorporated into 
the calibrators and may vary between different matrix sources, it may be less feasible to fix an assay 
range (59). Moreover, the analyte’s endogenous presence complicates the evaluation of the LLOQ and 
hence the determination of low analyte levels (60).  
In addition to standard addition, a surrogate matrix-approach, in which the authentic matrix is 
substituted, has been applied to circumvent the endogenous presence of vitamins. Leaney et al. 
evaluated different surrogate matrices (phosphate buffered saline (PBS), PBS with 2% bovine serum 
albumin (BSA) or 5% BSA and washed erythrocytes with PBS and 2% or 5% BSA) for the quantification of 
25OHD3 in VAMS samples (61). Remarkably, when pure PBS was used, 25OHD3 was retained on the 
device, as a poor recovery of 25OHD3 was observed. Interestingly, Delahaye et al. also observed a 
reduced recovery of paracetamol from VAMS, when applied in pure water (62). This suggests that 
analyte-polymer interactions, compromising extractability, may take place in the absence of matrix. In 
the case of 25OHD3, the recovery from VAMS samples was shown to be highly dependent on the amount 
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of proteins present in the surrogate matrix, increasing with increasing protein content. As vitamin D is 
highly plasma protein bound, the analyte is probably extracted from the VAMS sample attached to 
plasma proteins (when using an aqueous extraction solvent), indicating the importance of having a 
sufficient amount of protein in the surrogate matrix, to ensure reliable quantification. Therefore, as 
vitamin A and D are mainly present in plasma/serum, the surrogate matrix to quantify vitamin A or D 
commonly consists of washed erythrocytes, mixed with PBS containing BSA or human serum albumin 
(HSA) (50, 60, 63). Importantly, since vitamin A and D are endogenously bound to albumin, BSA and HSA 
batches may contain traces of those vitamins. Hence, Leaney et al. stressed the importance to screen 
BSA batches for their low presence of vitamin D prior to use (61). Finally, to demonstrate the suitability 
of a surrogate matrix, Matuszewski et al. showed that the relative ME between different matrices can be 
assessed by comparison of the slopes of the calibration lines established in the different matrices (64). 
Zhang et al. applied this approach to demonstrate the suitability of a surrogate matrix (washed 
erythrocytes mixed with PBS containing 2% BSA) to quantify retinol in DBS samples (50).  
2.5. ASSAY SENSITIVITY 
A major challenge associated with the use of dried blood microsamples to determine vitamin levels is the 
assay’s sensitivity. Due to the low sample volume and low analyte abundance, highly sensitive analytical 
methods are required. Moreover, when the analyte of interest is mainly present in serum/plasma, as is 
the case for vitamin A and D, sample volumes are even lower (32). Consequently, current methods are 
often only able to determine the major vitamin forms such as 25OHD3, 5-MTHF and TDP. However, in 
some cases, such as metabolism studies which aim at obtaining more insight into genetic variants, it is 
also relevant to look at other (minor) vitamin forms such as 24,25-dihydroxyvitamin D (24,25-diOHD), 
1,25-dihydroxyvitamin D (1,25-diOHD), tetrahydrofolate (THF), 5,10-methylenetetrahydrofolate (5,10-
CH2THF), 5-formyltetrahydrofolate (5FoTHF), nonphosphorylated thiamine, thiamine monophosphate 
(TMP), etc., which are now rarely determined in dried microsamples. 
The lipophilic nature and the absence of functional groups that facilitate ionization complicate the MS-
based analysis of vitamin A and D (65). Only Zhang et al. described an LC-MS/MS method for the 
determination of retinol in DBS, while others typically used LC-UV detection (29, 47-50). In contrast, 
vitamin D has commonly been measured via LC-MS/MS (Table 1), with chemical derivatization as the 
most common solution to improve sensitivity, via increasing its ionization capacity. However, this implies 
an additional time-consuming step and also complicates chromatography as two stereoisomers are 
formed. Therefore, several groups circumvented this derivatization step by analyzing whole DBS or 
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multiple subpunches, thereby increasing the sample size, to reach the required sensitivity (Table 1). This 
strategy may not be feasible in all instances. Kvaskoff et al. increased assay sensitivity by selectively 
removing PLs via a new sample cleanup procedure (30), while Jensen et al. performed 2D-
chromatography, allowing to inject a higher sample volume while minimizing ME via online sample 
cleanup (32).  
From the authors’ own experience, TDP determination via LC-MS/MS has proven to be challenging due 
to the analyte’s high polarity and ionogenic characteristics. Typically, TDP is determined via HPLC-
fluorescence using phosphate buffer as mobile phase, as recently done by Mathew et al. (43). However, 
due to its nonvolatility, this phosphate buffer is incompatible with LC-MS/MS. While 80% of thiamine in 
blood is present as TDP, nonphosphorylated thiamine and TMP are only present at very low 
concentrations. Moreover, the latter two thiamine vitamers are mainly present in plasma, which results 
in an even smaller sample volume available for analysis. Zhang et al. obtained sufficient sensitivity for 
the determination of nonphosphorylated thiamine from DBS by analyzing complete 40 L DBS and 
injecting a high sample volume (40 L) (51). 
Kopp and Rychlik described an LC-MS/MS method for the determination of 5-MTHF in DBS and VAMS 
samples (42, 66). Despite the smaller sample volume of VAMS (10.8 L) compared to DBS (50 L) 
samples, similar LLOQs were attained. This increase in assay sensitivity was mainly attributed to omitting 
the SPE step during sample preparation of VAMS samples. This SPE step was responsible for 43% loss of 
analyte level in DBS analysis. Furthermore, the use of a longer column resulted in better separation of 
the matrix compounds, reducing possible ME, which may decrease the analyte signal. 
2.6. STABILITY 
The assessment of vitamins in dried blood microsamples greatly depends on their stability during the 
entire analytical procedure, i.e. drying, transport and storage. Although dried blood microsampling has 
been described to increase stability, the latter depends on the analyte characteristics and should be 
evaluated on a case-by-case basis at the different conditions (temperature, relative humidity, time, etc.) 
representative for the eventual study conditions (13). 
For vitamin A and D, acceptable stability was observed at different storage conditions by several 
research groups. This may be related to their highly protein-bound nature, which may protect them from 
degradation. Zhang et al. evaluated the effect of a protectant, added to freshly prepared DBS, on retinol 
stability during drying (50). While retinol losses were observed in freshly prepared DBS ( 20%), they 
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found that treatment with AA or BHT could protect retinol from oxidation and therefore significantly 
improved stability during drying. This kind of approach, where antioxidants are deposited onto freshly 
prepared DBS samples, although feasible in centralized sampling settings, are not workable in the 
context of home-sampling. Alternatively, pre-impregnation of filter paper with the antioxidants may be 
evaluated. However, such approach may raise additional issues as the impregnated cards come in close 
contact with the pricked fingertip and may affect the spreading of the blood.  
By contrast, thiamine and its phosphate derivatives are amongst the most unstable water-soluble 
vitamins. Mathew et al. evaluated the stability of TDP in DBS and found the analyte to be stable during 
8h storage at room temperature (RT) (43). It should be noted that this latter study was performed in 
India, with ambient conditions of 34°C and 75% relative humidity. Within this time frame, samples 
should be transferred to -80°C to ensure long-term stability (6 months). Zhang et al. evaluated the 
stability of nonphosphorylated thiamine, riboflavin and pyridoxal-phosphate (PLP) in vacuum treated 
DBS (51). While thiamine was stable for 15 days of storage at RT, riboflavin and PLP were stable up till 1 
year. Furthermore, all analytes were stable during 7-day storage at 40°C and 50% humidity, mimicking 
the conditions in remote areas. Remarkably, while riboflavin levels decreased > 20% during 2h drying at 
RT, thiamine and PLP remained stable. Since riboflavin levels remained stable after drying during storage 
under vacuum, the authors applied an adjustment factor to account for this initial loss in riboflavin 
content. 
O’Broin et al. evaluated the stability of vitamin B12 in DSS stored for 7 days at 4°C, 20°C and 37°C and 
found that vitamin B12 was stable at all conditions (67). The same research group investigated the 
stability of total folate in both DBS and DSS (28, 68). While AA negatively affected folate stability in DBS, 
it improved the stability in DSS. The authors explained this phenomenon by AA’s ability to rapidly lyse 
erythrocytes, with as a consequence less protection against degradation then when folates remain 
incorporated in the erythrocytes. Folates in untreated DBS were only stable for a few days of storage at 
ambient temperature, while levels remained stable in DBS stored up till 1 year at -20°C. Folates in DSS 
were stable for 1 week at 20°C and 2 weeks at 4°C, from which the authors derived its potential for 
shipment by regular mail. However, actual temperatures may be a lot higher during summer. 
Zimmerman et al. evaluated long-term total folate stability during 9 months at different conditions (69). 
Folate concentrations substantially decreased when samples were stored at higher temperature (24-
27°C) and greater humidity (53-68%). Kopp and Rychlik evaluated the short-term stability of 5-MTHF in 
both DBS and VAMS samples (42, 66). 5-MTHF in VAMS samples was stable during 2.5h drying at RT. 
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Moreover, upon storage at -20°C, 5-MTHF was stable for two, respectively three weeks in DBS and VAMS 
samples.  
2.7. CLINICAL INTERPRETATION 
Vitamin levels are typically measured in plasma/serum (vitamin A, D, B2, B6, B9 (short-term status) and 
B12), erythrocytes (vitamin B9, long-term status) or whole blood (TDP).  
To allow the comparison of microsample-based results with existing results from previous studies and 
cut-off values in plasma/serum or erythrocytes, a conversion of microsample-based results is often 
required. Alternatively, new microsample-based cut-off values could be established. However, this will 
be very expensive and time consuming and furthermore, inconvenient for physicians as they are familiar 
with existing cut-off levels (70). The B/P ratio is an important factor concerning the correlation between 
dried blood microsample and plasma or erythrocyte concentrations. This ratio is to an important extent 
determined by a sample’s Hct (14). Ideally, the individual Hct of each sample is applied to convert the 
results from DBS/VAMS samples to equivalent plasma/serum or erythrocyte levels. However, often an 
average Hct value of the study population is used, e.g. women, men, neonates. Yet, this latter approach 
is only acceptable when the Hct range of that specific population is quite narrow. Karvaly et al. reported 
wide Hct ranges within a subpopulation; 0.42 (0.25-0.51) for males and 0.4 (0.26-0.44) for females, 
indicating the inappropriateness of using a single correction factor (71). Furthermore, the utilized 
average Hct value often differs between methods, even though similar target population may be 
considered, which further complicates method comparability. For example, within the discussed vitamin 
D publications, the average Hct applied for women ranged from 0.4-0.43, for men from 0.45-0.47 and for 
neonates from 0.5-0.6. Makwoski et al. and Muller et al. even used a single Hct value, independent of 
the gender (60, 72). Zhang et al. and Heath et al. set up a model to convert DBS-based concentrations for 
retinol and 25OHD, respectively (50, 73). The latter two research groups used two sets of DBS samples 
with their matching plasma/serum samples, a ‘test’ set and a ‘training’ set. The test set was used to 
establish a model describing the correlation between DBS and plasma/serum results, with evaluation of 
key predictors of vitamin D status (e.g. age, sex, month of sample collection, etc.) for their individual 
contribution to the model fit. The training set was used to test the model’s ability to predict plasma 
levels from DBS results. Heath et al. observed that the use of a sex-specific model did not fully account 
for differences between DBS and plasma results (73). Even though the Hct is strongly influenced by the 
sex, there are also physiological variations in Hct. Fallah et al. determined the individual Hct levels from a 
few additional drops of blood using a point-of-care test, the Hemocue B Hemoglobin Photometer (48). 
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However, this strategy is hard to conceive in a home-sampling context, as every patient would need such 
a device (14). Alternative methods to determine the Hct of a dried blood microsample can be used, as 
mentioned in section 2.2. and recently reviewed by Velghe et al. (15).  
Red blood cell folate (RCF) is recommended to assess the long-term folate status (74). Shreckengost et 
al. determined the hemoglobin (Hb) content of a DBS using the sodium laurylsulfate (SLS) microplate 
method (75, 76). Consequently, folate concentrations may be expressed as Hb folate (HF) (nmol/g) by 
dividing the DBS whole blood folate concentration by the measured Hb concentration. Subsequently, the 
corresponding RCF can be deduced from the HF using either a specific or population-based mean 
corpuscular hemoglobin concentration (MCHC) value. 
Once microsample-derived results are converted to their equivalent plasma/serum or erythrocyte 
results, the correlation between both methods (alternative vs. conventional) should be evaluated to 
demonstrate the potential of the alternative sampling strategy and the validity of the obtained results 
(13). To compare two methods, regression analysis (Deming, Passing-Bablok) should be performed, 
followed by an agreement and bias estimation test (Bland-Altman) (77-79). Although a Bland-Altman plot 
is shown in most of the discussed publications, this should be accompanied by a correct interpretation of 
the results, which is often lacking (80). The mean bias should be accompanied by its 95% confidence 
interval, ideally containing zero. If this is not the case, it should be discussed whether the observed bias 
is still acceptable, which highly depends on the purpose of the method. Furthermore, the limits of 
agreement (LoAs), which will statistically cover 95% of the results, should be calculated. The span 
covered by these LoAs is an indication of the agreement between two methods, and pre-set (clinical) 
criteria should be applied to discern whether the observed differences are acceptable. For example, for 
vitamin D, most of the published methods present wide limits of agreement, illustrating high variation of 
the results. However, Jensen et al. showed that all of their sample comparisons fell within the total 
allowable error (TAE) (32). Factors contributing to the high variation observed in many papers may 
possibly be the use of a single correction factor or mean Hct value to convert DBS results to equivalent 
plasma/serum results.  
For TDP (vitamin B1), which is already routinely measured in whole blood, the results obtained from 
dried blood microsamples should still be compared with those from conventional liquid blood. E.g., as 
capillary blood consists of a mixture of venous and arterial blood and interstitial fluid, there might be a 
difference between venous and capillary results. However, such differences were mostly reported for 
exogenous substances as these require a distribution phase (13). 
16 
 
 Ideally, the validity of a particular method can be demonstrated using commercially available 
secondary (matrix-based) reference materials (SRM) with a known vitamin content. Different SRMs, 
containing specific vitamins, are commercially available through different institutes. NIST provides 
reference serum material for vitamin A (SRM 968f, SRM 1950), vitamin D (SRM 972a, SRM 1949, SRM 
1950, SRM 2973), vitamin B6 (SRM 1950, SRM 3950) and folates (SRM 1950, SRM 3949). The National 
Institute for Biological Standards and Control (NIBSC) offers reference material for vitamin B12 (03/178, 
serum) and folates (03/178, serum; 95/528, whole blood). Ideally, these SRMs resemble the native 
samples as close as possible (i.e. unadulterated, non-spiked human material) and are compatible with 
dried microsample analysis. As vitamins B1, B6 and B9 are mainly present in the erythrocytes, reference 
whole liquid blood material is preferred to evaluate dried blood microsampling methods. However, this 
material is only available for vitamin B9 (NIBSC 95/528). Yet, none of the microsample-based folate 
methods evaluated the application of this blood reference material onto DBS cards or VAMS. For vitamin 
B12, O’Broin et al. spotted the compatible liquid serum reference material IRR 81/563 onto filter paper to 
evaluate their DSS method (67). Although no compatible reference materials (i.e. because of a different 
matrix) were available for the determination of vitamin A and D in whole blood microsamples, serum 
reference material was mixed with washed erythrocytes, after which the prepared whole blood was 
spiked onto blank DBS cards (32, 50). Also for other analytes, serum reference material has successfully 
been used to allow the generation of dried blood microsample quality controls to demonstrate a 
method’s validity (81). 
It is important to note that blood SRMs are not necessarily compatible with dried microsampling 
methods, as commutability issues may arise (13, 82). These issues may be caused by (i) effects resulting 
from lyophilizing and reconstituting blood, (ii) differences in viscosity compared to fresh blood, which 
may result in incorrect conclusions when a DBS sub-punch is analyzed, and (iii) differences in extraction 
efficiency compared to native samples. A good way to assess the trueness of calibration and the 
compatibility of a SRM for a specific dried microsampling method is the parallel analysis of native 
materials and SRMs, both in their dried and liquid form. If the results for the liquid SRM samples are 
acceptable, but those for their dried equivalents are not, the SRM may be unsuited for the specific 
microsample application. The same holds true when the results of liquid and dried SRM match, whilst 




While dried blood microsampling offers some important advantages to diagnose vitamin 
deficiencies in e.g. remote regions, the number of published methods in this field is relatively limited, likely 
owing to the (many) associated challenges. Therefore, we discussed some important issues that may be 
encountered during the set-up of a method for the determination of vitamins in microsamples. 
LC-MS/MS is the method of choice to analyze microsamples. Yet, achieving sufficient sensitivity to 
determine low vitamin levels in micro-volumes of blood remains challenging. Additional measures such as 
extensive sample cleanup, derivatization and increase of sample size can be evaluated to attain the 
required sensitivity. Moreover, the endogenous presence of vitamins complicates their quantification. 
Although standard addition has been described as a strategy to cope with this latter issue, this approach 
is not compatible with the direct application of a drop of blood from the fingertip onto filter paper. 
Furthermore, standard addition challenges the determination of the method’s sensitivity or LLOQ. 
Therefore, alternative procedures, such as the use of a surrogate matrix, should be considered.  
Microsample-specific parameters, such as punch site, spotting volume, etc. should be evaluated 
in an early stage of method development, and should be fixed during the entire analytical process, as they 
may influence the final analytical results. In general, the use of dried microsamples can be seen as a 
strategy to facilitate sample preparation, as analytes can be selectively extracted from the card or device, 
consuming lower amounts of reagents The specific extraction procedure depends on the analyte’s 
characteristics and the aimed sensitivity. More extensive procedures such as solid phase extraction may 
be recommended when sensitivity issues occur due to matrix effects. Dried microsampling definitely 
showed a positive impact on the stability of all vitamins described. However, it remains essential to further 
evaluate stability on a case-by-case basis at the different conditions (temperature, relative humidity, time, 
etc.) representative for the eventual study conditions. 
Not only may the Hct influence important analytical parameters such as accuracy, recovery and 
ME, the Hct may also affect the B/P distribution of an analyte and, consequently, the clinical interpretation 
of the results. As most clinical reference ranges are set in plasma/serum or whole liquid blood, the results 
obtained by the alternative method should be critically compared with those obtained by a conventional 
method to demonstrate the suitability of microsampling as a valid alternative. 
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Table 1. Overview of published methods for the determination of vitamins in dried microsamples. 5-MTHF, 5-methyltetrahydrofolate; 25(OH)D2, 25-
hydroxy vitamin D2; 25(OH)D3, 25-hydroxy vitamin D3; 24,25(OH)2D3, 24,25-dihydroxy vitamin D3; DBS, dried blood spot; DBSP, plasma concentration measured in dried blood spots; 
DPS, dried plasma spot; HPLC, high performance liquid chromatography; LC-MS/MS, liquid chromatography-tandem mass spectrometry; LLOQ, lower limit of quantification; NS, 
not specified; TDP, thiamine diphosphate; TMP, thiamine monophosphate; UV, ultraviolet; VAMS, volumetric absorptive microsampling. 
Analyte Reference Analytical technique LLOQ Microsample type C = Complete analysis 
P = Punch 
Vitamin A 
Retinol (47)  HPLC-UV NS DBS  P: 6.35 mm Ø punch from 50 µL spot 
Retinol (29) HPLC-UV 0.5 µmol/L DBS  P: 6.35 mm Ø punch from 30 µL spot 
Retinol (48) HPLC-UV NS DBS  C: 60 µL spot 
Retinol (49) HPLC-UV 0.05 µg/mL DBS and DPS 
  
DBS: P: 8.5 mm Ø punch from 40 µL spot 
DPS: C: 40 µL spot 
Retinol (50) LC-MS/MS 0.04 µg/mL DBS C: 40 µL spot  
Vitamin B1 
Thiamine (51) LC-MS/MS 0.5 ng/mL DBS  C: 40 µL spot  
TDP (43) HPLC-fluorimetry 10 ng/mL DBS  C: 40 µL spot  
Thiamine, TMP, TDP (83) HPLC-fluorimetry 1.5-3 nmol/L DBS P: 6.35 mm Ø punch from 40 µL spot 
Vitamin B2 
Riboflavin (51) LC-MS/MS 0.2 ng/mL DBS C: 40 µL spot 
Riboflavin (52) LC-MS/MS 2 ng/mL DBS  C: 20 µL spot 
Vitamin B6      
Pyridoxal 5'-phosphate (51) LC-MS/MS 0.5 ng/mL DBS  C: 40 µL spot 
Vitamin B9 






Total folate (26) Microbiological assay  NS DBS  C: 50 µL spot 
Total folate (28) Microbiological assay  NS DSS                               C: 50 µL  
Total folate (69) Microbiological assay  NS DBS   P: 6.35 mm Ø punch 
  Analyte Reference Analytical technique LLOQ Microsample type C = Complete analysis 
P = Punch 
5-MTHF (66) LC-MS/MS 25 nmol/L (DBS) 
6.3 nmol/L (DBSP) 
4.4 nmol/L (DPS) 
DBS and DPS  C: 50 µL spot for DBS and DBSP 
C: 30 µL spot for DPS 
5-MTHF (42) LC-MS/MS  26 nmol/L VAMS C: complete sample tip 
Vitamin B12 
Vitamin B12 (67) Microbiological assay NS DSS  C: 50 µL spot 
Vitamin D 
25(OH)D2, 25(OH)D3 (84) LC-MS/MS NS DBS  P: 4 x 6 mm Ø punch  
25(OH)D2, 25(OH)D3 (85) LC-MS/MS 7.7-10.7 nmol/L DBS  P: 3.2 mm Ø punch 
25(OH)D2, 25(OH)D3 (86) LC-MS/MS 4 ng/mL (LOD) DBS  P: 6 mm Ø punch  
25(OH)D3 (63) LC-MS/MS 3.0 ng/mL DBS P: 2x 3 mm Ø punch   
25(OH)D3 (27) LC-MS/MS NS DBS  P: 3.2 mm Ø punch 
25(OH)D3 (87) LC-MS/MS 1.5 ng/mL DBS                               P: 3.2 mm Ø punch 
25(OH)D2, 25(OH)D3 (88) LC-MS/MS 32.5 nmol/L DBS   P: 2 x 3.2 mm Ø punch 
25(OH)D2, 25(OH)D3 (30) LC-MS/MS 5 nmol/L DBS P: 3.2 mm Ø punch from 50 μl spot 
25(OH)D2, 25(OH)D3, 3-epi-25(OH)D3 (72) LC-MS/MS 1.5 ng/mL DBS  P: 2x 6.0 mm Ø punch   
3α-25(OH)D3, 3β-25(OH)D3 (60) LC-MS/MS 0.1 – 1 ng/mL DBS P: 5 mm Ø punch from 50 µL spot 
25(OH)D2, 25(OH)D3 (71) LC-MS/MS 3.85 – 4.62 ng/mL (DBS) 
1 ng/mL (DSS) 
DBS and DSS  P: 3 x 5.5 mm Ø punch from 80 µL spot 
25(OH)D2, 25(OH)D3 (32) LC-MS/MS 10.9 - 12.8 nmol/L DBS  P: 3.2 mm Ø punch 
25(OH)D2, 25(OH)D3, 3-epi-25(OH)D3 and 
24,25(OH)2D3 
(65) LC-MS/MS 0.04 - 0.48 ng/mL DBS  
 
P: 2 x 3 mm Ø punch 
25(OH)D3 (46) LC-MS/MS 0.5 nmol/L DBS  P: 3.2 mm Ø punch from 50 µL spot 





Jana Verstraete would like to thank the Research Foundation Flanders (FWO) for granting her a PhD 
fellowship (1S61617N). Christophe Stove acknowledges the Ghent University Special Research Fund 
(GOA 01G00409).  
 
References:  
1. WHO. Micronutrients  [cited 2020 April 9]. Available from: 
https://www.who.int/nutrition/topics/micronutrients/en/. 
2. Pfotenhauer KM, Shubrook JH. Vitamin D Deficiency, Its Role in Health and Disease, and 
Current Supplementation Recommendations. J. Am. Osteopath. Assoc. 2017;117(5):301-5. 
3. Bates CJ. Diagnosis and detection of vitamin deficiencies. Br. Med. Bull. 1999;55(3):643-57. 
4. Valero YCG, Wallis SC, Lipman J, Stove C, Roberts JA, Parker SL. Clinical application of 
microsampling versus conventional sampling techniques in the quantitative bioanalysis of antibiotics: 
a systematic review. Bioanalysis. 2018;10(6):407-23. 
5. Lei BUW, Prow TW. A review of microsampling techniques and their social impact. Biomed. 
Microdevices. 2019;21(4). 
6. Londhe V, Rajadhyaksha M. Opportunities and obstacles for microsampling techniques in 
bioanalysis: Special focus on DBS and VAMS. J. Pharm. Biomed. Anal. 2020;182. 
7. Bowen CL, Hemberger MD, Kehler JR, Evans CA. Utility of dried blood spot sampling and 
storage for increased stability of photosensitive compounds. Bioanalysis. 2010;2(11):1823-8. 
8. Velghe S, Deprez S, Stove CP. Fully automated therapeutic drug monitoring of anti-epileptic 
drugs making use of dried blood spots. J. Chromatogr. A. 2019;1601:95-103. 
9. Luginbuhl M, Gaugler S. The application of fully automated dried blood spot analysis for liquid 
chromatography -tandem mass spectrometry using the CAMAG DBS-MS 500 autosampler. Clin. 
Biochem. 2020;82:33-9. 
10. Henion J,  Oliveira RV, Li F, Foley T & Pomponio R. Dried blood spots: the future.  Microsampling 
in Pharmaceutical Bioanalysis 2013. 
11. Oliveira RV, Henion J, Wickremsinhe ER. Automated direct extraction and analysis of dried 
blood spots employing on-line SPE high-resolution accurate mass bioanalysis. Bioanalysis. 
2014;6(15):2027-41. 
12. Duthaler U, Berger B, Erb S, Battegay M, Letang E, Gaugler S, et al. Automated high throughput 
analysis of antiretroviral drugs in dried blood spots. J. Mass Spectrom. 2017;52(8):534-42. 
13. Capiau S, Veenhof H, Koster RA, Bergqvist Y, Boettcher M, Halmingh O, et al. Official 
International Association for Therapeutic Drug Monitoring and Clinical Toxicology Guideline: 
Development and Validation of Dried Blood Spot-Based Methods for Therapeutic Drug Monitoring. 
Ther. Drug Monit. 2019;41(4):409-30. 
14. De Kesel PM, Sadones N, Capiau S, Lambert WE, Stove CP. Hemato-critical issues in 
quantitative analysis of dried blood spots: challenges and solutions. Bioanalysis. 2013;5(16):2023-41. 
21 
 
15. Velghe S, Delahaye L, Stove CP. Is the hematocrit still an issue in quantitative dried blood spot 
analysis? J. Pharm. Biomed. Anal. 2019;163:188-96. 
16. Delahaye L, Veenhof H, Koch B, Alffenaar J-W, Linden R, Stove C. Alternative sampling devices 
to collect dried blood microsamples: state-of-the art. Ther. Drug Monit. [submitted] 
17. Deprez S, Paniagua-Gonzalez L, Velghe S, Stove CP. Evaluation of the Performance and 
Hematocrit Independence of the HemaPEN as a Volumetric Dried Blood Spot Collection Device. Anal. 
Chem.. 2019;91(22):14467-75. 
18. Protti M, Marasca C, Cirrincione M, Cavalli A, Mandrioli R, Mercolini L. Assessment of capillary 
volumetric blood microsampling for the analysis of central nervous system drugs and metabolites. 
Analyst. 2020;145(17):5744-53. 
19. Lenk G, Sandkvist S, Pohanka A, Stemme G, Beck O, Roxhed N. A disposable sampling device to 
collect volume-measured DBS directly from a fingerprick onto DBS paper. Bioanalysis. 
2015;7(16):2085-94. 
20. Velghe S, Stove CP. Evaluation of the Capitainer-B Microfluidic Device as a New Hematocrit-
Independent Alternative for Dried Blood Spot Collection. Anal. Chem. 2018;90(21):12893-9. 
21. Beck O, Moden NK, Seferaj S, Lenk G, Helander A. Study of measurement of the alcohol 
biomarker phosphatidylethanol (PEth) in dried blood spot (DBS) samples and application of a 
volumetric DBS device. Clin. Chim. Acta. 2018;479:38-42. 
22. Li YY, Henion J, Abbott R, Wang P. The use of a membrane filtration device to form dried plasma 
spots for the quantitative determination of guanfacine in whole blood. Rapid Commun. Mass 
Spectrom. 2012;26(10):1208-12. 
23. Kim JH, Woenker T, Adamec J, Regnier FE. Simple, Miniaturized Blood Plasma Extraction 
Method. Anal. Chem. 2013;85(23):11501-8. 
24. Sturm R, Henion J, Abbott R, Wang P. Novel membrane devices and their potential utility in 
blood sample collection prior to analysis of dried plasma spots. Bioanalysis. 2015;7(16):1987-2002. 
25. Majda A, Wietecha-Posluszny R, Swiadro M, Mrochem K, Koscielniak P. Dried blood spots 
sampling in case samples deprived of hematocrit level information - Investigation and calculation 
strategy. J. Chromatogr. B Biomed Appl. 2019;1124:308-12. 
26. O'Broin SD, Gunter EW. Screening of folate status with use of dried blood spots on filter paper. 
Am. J. Clin. Nutr. 1999;70(3):359-67. 
27. Kvaskoff D, Ko P, Simila HA, Eyles DW. Distribution of 25-hydroxyvitamin D3 in dried blood 
spots and implications for its quantitation by tandem mass spectrometry. J. Chromatogr. B Biomed. 
Appl. 2012;901:47-52. 
28. O'Broin S, Gunter E. Dried-serum spot assay for folate. Clin. Chem. 2002;48(7):1128-30. 
29. Erhardt JG, Craft NE, Heinrich F, Biesalski HK. Rapid and simple measurement of retinol in 
human dried whole blood spots. Nutr. J. 2002;132(2):318-21. 
30. Kvaskoff D, Heath AK, Simila HA, Ko P, English DR, Eyles DW. Minimizing Matrix Effects for the 
Accurate Quantification of 25-Hydroxyvitamin D Metabolites in Dried Blood Spots by LC-MS/MS. Clin. 
Chem. 2016;62(4):639-46. 
31. Capiau S, Stove VV, Lambert WE, Stove CP. Prediction of the Hematocrit of Dried Blood Spots 
via Potassium Measurement on a Routine Clinical Chemistry Analyzer. Anal. Chem. 2013;85(1):404-10. 
32. Jensen BP, Saraf R, Ma J, Berry S, Grant CC, Camargo CA, Jr., et al. Quantitation of 25-
hydroxyvitamin D in dried blood spots by 2D LC-MS/MS without derivatization and correlation with 
22 
 
serum in adult and pediatric studies. Clin. Chim Acta; international journal of clinical chemistry. 
2018;481:61-8. 
33. De Kesel PMM, Capiau S, Stove VV, Lambert WE, Stove CP. Potassium-based algorithm allows 
correction for the hematocrit bias in quantitative analysis of caffeine and its major metabolite in dried 
blood spots. Anal. Bioanal. Chem. 2014;406(26):6749-55. 
34. Capiau S, Stove C. Hematocrit prediction in volumetric absorptive microsamples J. Pharm 
Biomed. Anal. 2020. 
35. Kadjo AF, Stamos BN, Shelor CP, Berg JM, Blount BC, Dasgupta PK. Evaluation of Amount of 
Blood in Dry Blood Spots: Ring-Disk Electrode Conductometry. Anal. Chem. 2016;88(12):6531-7. 
36. Dvorak M, Rysava L, Kuban P. Capillary Electrophoresis with Capacitively Coupled Contactless 
Conductivity Detection for Quantitative Analysis of Dried Blood Spots with Unknown Blood Volume. 
Anal. Chem. 2020;92(1):1557-64. 
37. Capiau S, Wilk LS, Aalders MCG, Stove CP. A Novel, Nondestructive, Dried Blood Spot-Based 
Hematocrit Prediction Method Using Noncontact Diffuse Reflectance Spectroscopy. Anal. Chem. 
2016;88(12):6538-46. 
38. Capiau S, Wilk LS, De Kesel PMM, Aalders MCG, Stove CP. Correction for the Hematocrit Bias 
in Dried Blood Spot Analysis Using a Nondestructive, Single-Wavelength Reflectance-Based Hematocrit 
Prediction Method. Anal. Chem. 2018;90(3):1795-804. 
39. Oostendorp M, El Amrani M, Diemel EC, Hekman D, van Maarseveen EM. Measurement of 
Hematocrit in Dried Blood Spots Using Near-Infrared Spectroscopy: Robust, Fast, and Nondestructive. 
Clin. Chem. 2016;62(11):1534-6. 
40. Denniff P, Spooner N. Volumetric Absorptive Microsampling: A Dried Sample Collection 
Technique for Quantitative Bioanalysis. Anal. Chem. 2014;86(16):8489-95. 
41. De Kesel PM, Lambert WE, Stove CP. Does volumetric absorptive microsampling eliminate the 
hematocrit bias for caffeine and paraxanthine in dried blood samples? A comparative study. Anal. 
Chim. Acta. 2015;881:65-73. 
42. Kopp M, Rychlik M. Assessing Volumetric Absorptive Microsampling Coupled with Stable 
Isotope Dilution Assay and Liquid Chromatography-Tandem Mass Spectrometry as Potential Diagnostic 
Tool for Whole Blood 5-Methyltetrahydrofolic Acid. Front. Nutr. 2017;4:9. 
43. Mathew EM, Sakore P, Lewis L, Manokaran K, Rao P, Moorkoth S. Development and validation 
of a dried blood spot test for thiamine deficiency among infants by HPLC-fluorimetry. Biomed. 
Chromatogr. 2019;33(11):e4668. 
44. Abu-Rabie P, Denniff P, Spooner N, Chowdhry BZ, Pullen FS. Investigation of Different 
Approaches to Incorporating Internal Standard in DBS Quantitative Bioanalytical Workflows and Their 
Effect on Nullifying Hematocrit-Based Assay Bias. Anal. Chem. 2015;87(9):4996-5003. 
45. Mano Y, Kita K, Kusano K. Hematocrit-independent recovery is a key for bioanalysis using 
volumetric absorptive microsampling devices, Mitra(TM). Bioanalysis. 2015;7(15):1821-9. 
46. Zakaria R, Allen KJ, Koplin JJ, Roche P, Greaves RF. Candidate reference method for 
determination of vitamin D from dried blood spot samples. Clin. Chem. Lab. Med. 2020;58(5):817-27. 
47. Craft NE, Haitema T, Brindle LK, Yamini S, Humphrey JH, West KP, Jr. Retinol analysis in dried 
blood spots by HPLC. J. Nutr. 2000;130(4):882-5. 
48. Fallah E, Peighambardoust SH. Validation of the Use of Dried Blood Spot (DBS) Method to 
Assess Vitamin A Status. Health Promot. Perspect. 2012;2(2):180-9. 
23 
 
49. Huang Y, Clements PR, Gibson RA. Robust measurement of vitamin A status in plasma and 
blood dried on paper. Prostaglandins Leukot. Essent. Fatty Acids. 2015;102-103:31-6. 
50. Zhang M, Wu Y, Wang F, Liu H, Zhang S, Zhang Z, et al. Improving long-term stability of retinol 
in dried blood spots and quantification of its levels via a novel LC-MS/MS method. Anal. Bioanal. Chem. 
2019;411(30):8073-80. 
51. Zhang M, Liu H, Huang X, Shao L, Xie X, Wang F, et al. A novel LC-MS/MS assay for vitamin B1, 
B2 and B6 determination in dried blood spots and its application in children. J. Chromatogr. B Biomed. 
Appl. 2019;1112:33-40. 
52. Lin Y, Chen JH, He R, Tang B, Jiang L, Zhang X. A fully validated high-throughput liquid 
chromatography tandem mass spectrometry method for automatic extraction and quantitative 
determination of endogenous nutritional biomarkers in dried blood spot samples. J. Chromatogr. A. 
2020:461092. 
53. Deglon J, Thomas A, Mangin P, Staub C. Direct analysis of dried blood spots coupled with mass 
spectrometry: concepts and biomedical applications. Anal. Bioanal. Chem. 2012;402(8):2485-98. 
54. U.S. Department of Health and Human Serives; Food and Drug Administration; Center for Drug 
Evaluation and Research (CDER); Center for Veterinary Medicine (CVM). Bioanalytical Method 
Validation Guidance on Industry. 2018. 
55. European Medicines Agency. Guideline on bioanalytical method validation. 2012. 
56. Thakare R, Chhonker YS, Gautam N, Alamoudi JA, Alnouti Y. Quantitative analysis of 
endogenous compounds. J. Pharm. Biomed. Anal. 2016;128:426-37. 
57. van de Merbel NC. Quantitative determination of endogenous compounds in biological 
samples using chromatographic techniques. Trac-Trends Anal. Chem. 2008;27(10):924-33. 
58. Li WL, Cohen LH. Quantitation of endogenous analytes in biofluid without a true blank matrix. 
Anal. Chem. 2003;75(21):5854-9. 
59. Jones BR, Schultz GA, Eckstein JA, Ackermann BL. Surrogate matrix and surrogate analyte 
approaches for definitive quantitation of endogenous biomolecules. Bioanalysis. 2012;4(19):2343-56. 
60. Muller MJ, Stokes CS, Volmer DA. Quantification of the 3alpha and 3beta epimers of 25-
hydroxyvitamin D3 in dried blood spots by LC-MS/MS using artificial whole blood calibration and 
chemical derivatization. Talanta. 2017;165:398-404. 
61. Leaney AE, Horner C, Grace PB, Mawson DH. Selection of a surrogate matrix for the 
quantification of an endogenous analyte in dried whole blood. Bioanalysis. 2020;12(6):409-18. 
62. Delahaye L, Dhont E, De Cock P, De Paepe P, Stove CP. Volumetric absorptive microsampling 
as an alternative sampling strategy for the determination of paracetamol in blood and cerebrospinal 
fluid. Anal. and Bioanal. Chem. 2019;411(1):181-91. 
63. Higashi T, Suzuki M, Hanai J, Inagaki S, Min JZ, Shimada K, et al. A specific LC/ESI-MS/MS 
method for determination of 25-hydroxyvitamin D3 in neonatal dried blood spots containing a 
potential interfering metabolite, 3-epi-25-hydroxyvitamin D3. J. Sep. Sci. 2011;34(7):725-32. 
64. Matuszewski BK. Standard line slopes as a measure of a relative matrix effect in quantitative 
HPLC-MS bioanalysis. J. Chromatogr B Biomed. Appl. 2006;830(2):293-300. 
65. Rola R, Kowalski K, Bienkowski T, Kolodynska-Goworek A, Studzinska S. Development of a 
method for multiple vitamin D metabolite measurements by liquid chromatography coupled with 
tandem mass spectrometry in dried blood spots. The Analyst. 2018;144(1):299-309. 
24 
 
66. Kopp M, Rychlik M. Quantitation of 5-Methyltetrahydrofolic Acid in Dried Blood Spots and 
Dried Plasma Spots by Stable Isotope Dilution Assays. PLoS One. 2015;10(11):e0143639. 
67. O'Broin SD, Kelleher BP. A dried serum spot assay for vitamin B(12). Clin. Chem. Lab. Med. 
2008;46(3):354-8. 
68. O'Broin SD, Kelleher BP, Davoren A, Gunter EW. Field-study screening of blood folate 
concentrations: specimen stability and finger-stick sampling. Am. J. Clin. Nutr. 1997;66(6):1398-405. 
69. Zimmerman RK, Slater ME, Langer EK, Ross JA, Spector LG. Long-term stability of folate in dried 
blood spots stored in several conditions. J. Pediatr. 2013;163(2):596-7 e1. 
70. Capiau S, Alffenaar J-W, Stove C. Clinical challenges in therapeutic drug monitoring : special 
populations, physiological conditions and pharmacogenomics. In: Clarke W DA, editor. Alternative 
sampling strategies for therapeutic drug monitoring. Amsterdam, The Netherlands: Elsevier; 2016. p. 
279–336. 
71. Karvaly G, Molnar-Vilagos G, Kovacs K, Meszaros K, Patocs A, Vasarhelyi B. Evaluation of the 
Analytical and Clinical Concordance of 25-Hydroxyvitamin D Levels in Dried Blood Spots, Dried Serum 
Spots, and Serum as Potential Biorepository Specimens. Biopreserv. Biobank. 2017;15(4):285-92. 
72. Makowski AJ, Rathmacher JA, Horst RL, Sempos CT. Simplified 25-Hydroxyvitamin D 
Standardization and Optimization in Dried Blood Spots by LC-MS/MS. J. AOAC Int. 2017;100(5):1328-
36. 
73. Heath AK, Williamson EJ, Ebeling PR, Kvaskoff D, Eyles DW, English DR. Measurements of 25-
hydroxyvitamin D concentrations in archived dried blood spots are reliable and accurately reflect those 
in plasma. J. Clin Endocrinol. Metab. 2014;99(9):3319-24. 
74. WHO. Serum and red blood cell folate concentrations for assessing folate status in populations. 
Vitamin and Mineral Nutrition Information System. Geneva; 2012. 
75. Shreckengost CH, Kim AW, Whitaker SH, Weng L, Pearce BD, Kaiser BN. Dried blood spot 
microbiological assay indicates high prevalence of folate deficiency in rural adult men and women in 
the Haitian Central Plateau. Int. Health. 2019;11(6):487-95. 
76. Richardson G, Marshall D, Keevil BG. Prediction of haematocrit in dried blood spots from the 
measurement of haemoglobin using commercially available sodium lauryl sulphate. Ann. Clin. 
Biochem. 2018;55(3):363-7. 
77. Passing H, Bablok W. A New Biometrical Procedure for Testing the Equality of Measurements 
from 2 Different Analytical Methods - Application of Linear-Regression Procedures for Method 
Comparison Studies in Clinical-Chemistry .1. J. Clin. Chem.Clin. Biochem. 1983;21(11):709-20. 
78. Linnet K. Evaluation of Regression Procedures for Methods Comparison Studies. Clin. Chem. 
1993;39(3):424-32. 
79. Bland JM, Altman DG. Measuring agreement in method comparison studies. Stat. Methods 
Med. Res. 1999;8(2):135-60. 
80. Dewitte K, Fierens C, Stockl D, Thienpont LM. Application of the Bland-Altman plot for 
interpretation of method-comparison studies: A critical investigation of its practice. Clin. Chem. 
2002;48(5):799-801. 
81. Velghe S, Stove CP. Volumetric absorptive microsampling as an alternative tool for therapeutic 
drug monitoring of first-generation anti-epileptic drugs. Anal. Bioanal. Chem. 2018;410(9):2331-41. 
82. Capiau S, Bolea-Fernandez E, Balcaen L, Van Der Straeten C, Verstraete AG, Vanhaecke F, et al. 
Development, validation and application of an inductively coupled plasma - mass spectrometry 
25 
 
method to determine cobalt in metal-on-metal prosthesis patients using volumetric absorptive 
microsampling. Talanta. 2020;208. 
83. Huang Y, Gibson RA, Green TJ. Measuring thiamine status in dried blood spots. Clin. Chim. Acta. 
2020;509:52-9. 
84. Newman MS, Brandon TR, Groves MN, Gregory WL, Kapur S, Zava DT. A liquid 
chromatography/tandem mass spectrometry method for determination of 25-hydroxy vitamin D2 and 
25-hydroxy vitamin D3 in dried blood spots: a potential adjunct to diabetes and cardiometabolic risk 
screening. J. Diabetes Sci. Technol. 2009;3(1):156-62. 
85. Eyles D, Anderson C, Ko P, Jones A, Thomas A, Burne T, et al. A sensitive LC/MS/MS assay of 
25OH vitamin D3 and 25OH vitamin D2 in dried blood spots. Clin. Chim. Acta. 2009;403(1-2):145-51. 
86. Larkin EK, Gebretsadik T, Koestner N, Newman MS, Liu Z, Carroll KN, et al. Agreement of blood 
spot card measurements of vitamin D levels with serum, whole blood specimen types and a dietary 
recall instrument. PLoS One. 2011;6(1):e16602. 
87. Ogawa S, Ooki S, Morohashi M, Yamagata K, Higashi T. A novel Cookson-type reagent for 
enhancing sensitivity and specificity in assessment of infant vitamin D status using liquid 
chromatography/tandem mass spectrometry. Rapid Commun. Mass Spectrom. 2013;27(21):2453-60. 
88. Hoeller U, Baur M, Roos FF, Brennan L, Daniel H, Fallaize R, et al. Application of dried blood 
spots to determine vitamin D status in a large nutritional study with unsupervised sampling: the 
Food4Me project. Br. J. Nutr. 2016;115(2):202-11. 
 
 
